 Jordan Hoffman
Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Perfusion | 12 | 2025 | 211 | 4.300 |
Why?
| | Tissue and Organ Procurement | 14 | 2025 | 314 | 4.030 |
Why?
| | Organ Preservation | 12 | 2025 | 102 | 3.610 |
Why?
| | Heart Transplantation | 13 | 2024 | 747 | 2.990 |
Why?
| | Tissue Donors | 15 | 2025 | 417 | 1.800 |
Why?
| | Lung Transplantation | 5 | 2025 | 308 | 1.300 |
Why?
| | Lichens | 2 | 2023 | 15 | 1.000 |
Why?
| | Consensus | 3 | 2024 | 679 | 0.930 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 46 | 0.850 |
Why?
| | Tissue and Organ Harvesting | 1 | 2024 | 70 | 0.840 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 30 | 0.840 |
Why?
| | Genome, Mitochondrial | 1 | 2023 | 28 | 0.800 |
Why?
| | Terminology as Topic | 1 | 2024 | 216 | 0.790 |
Why?
| | Cold Ischemia | 1 | 2021 | 30 | 0.710 |
Why?
| | Cardiac Surgical Procedures | 3 | 2024 | 530 | 0.680 |
Why?
| | Graft Rejection | 2 | 2023 | 620 | 0.590 |
Why?
| | Vascular Stiffness | 1 | 2023 | 493 | 0.580 |
Why?
| | Organ Transplantation | 4 | 2024 | 247 | 0.570 |
Why?
| | Heart Failure | 4 | 2023 | 2228 | 0.500 |
Why?
| | Thoracic Injuries | 1 | 2016 | 55 | 0.480 |
Why?
| | Graft Survival | 5 | 2025 | 533 | 0.450 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2022 | 236 | 0.450 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2022 | 292 | 0.450 |
Why?
| | Aorta, Thoracic | 1 | 2016 | 267 | 0.410 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2016 | 250 | 0.400 |
Why?
| | Wounds, Nonpenetrating | 1 | 2016 | 275 | 0.390 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1902 | 0.380 |
Why?
| | Humans | 40 | 2025 | 136783 | 0.370 |
Why?
| | Stents | 1 | 2016 | 528 | 0.360 |
Why?
| | Ventricular Function, Right | 3 | 2023 | 283 | 0.360 |
Why?
| | Heart Ventricles | 4 | 2021 | 792 | 0.360 |
Why?
| | Surgeons | 3 | 2025 | 296 | 0.350 |
Why?
| | Rectal Neoplasms | 1 | 2009 | 149 | 0.280 |
Why?
| | Adult | 14 | 2025 | 37616 | 0.280 |
Why?
| | Rectum | 1 | 2009 | 185 | 0.280 |
Why?
| | Death | 3 | 2024 | 118 | 0.280 |
Why?
| | Carcinoma | 1 | 2009 | 236 | 0.270 |
Why?
| | Brain Death | 2 | 2024 | 46 | 0.270 |
Why?
| | Survival Analysis | 3 | 2021 | 1319 | 0.260 |
Why?
| | Retrospective Studies | 10 | 2024 | 15564 | 0.240 |
Why?
| | Heart-Assist Devices | 2 | 2021 | 552 | 0.230 |
Why?
| | ABO Blood-Group System | 1 | 2025 | 51 | 0.230 |
Why?
| | Resource Allocation | 1 | 2025 | 51 | 0.230 |
Why?
| | Intraoperative Complications | 1 | 2025 | 138 | 0.220 |
Why?
| | Donor Selection | 1 | 2024 | 77 | 0.210 |
Why?
| | Follow-Up Studies | 5 | 2025 | 5115 | 0.210 |
Why?
| | Costs and Cost Analysis | 1 | 2024 | 205 | 0.210 |
Why?
| | Synteny | 1 | 2023 | 15 | 0.210 |
Why?
| | Waiting Lists | 2 | 2025 | 262 | 0.200 |
Why?
| | Allografts | 1 | 2023 | 146 | 0.200 |
Why?
| | Shock | 1 | 2024 | 95 | 0.200 |
Why?
| | Cardiac Catheterization | 2 | 2023 | 527 | 0.200 |
Why?
| | Benzofurans | 1 | 2022 | 21 | 0.200 |
Why?
| | Ascomycota | 1 | 2022 | 32 | 0.190 |
Why?
| | Heart-Lung Transplantation | 1 | 2022 | 14 | 0.190 |
Why?
| | Heart Valve Prosthesis | 1 | 2023 | 116 | 0.180 |
Why?
| | Middle Aged | 12 | 2025 | 33200 | 0.180 |
Why?
| | Prostatic Neoplasms | 1 | 2009 | 1031 | 0.180 |
Why?
| | Hepatitis C | 1 | 2023 | 263 | 0.170 |
Why?
| | Pulmonary Artery | 2 | 2023 | 1082 | 0.170 |
Why?
| | Cardiac Output | 1 | 2020 | 164 | 0.170 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2019 | 31 | 0.160 |
Why?
| | Human Embryonic Stem Cells | 1 | 2019 | 24 | 0.160 |
Why?
| | Myocardial Contraction | 1 | 2020 | 340 | 0.150 |
Why?
| | CpG Islands | 1 | 2019 | 159 | 0.150 |
Why?
| | Biological Evolution | 1 | 2023 | 464 | 0.150 |
Why?
| | Phylogeny | 1 | 2023 | 896 | 0.150 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2022 | 360 | 0.150 |
Why?
| | Vena Cava, Inferior | 1 | 2019 | 71 | 0.150 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 152 | 0.150 |
Why?
| | Glucose | 1 | 2023 | 1019 | 0.150 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 316 | 0.150 |
Why?
| | Predictive Value of Tests | 1 | 2023 | 2030 | 0.140 |
Why?
| | Heart Atria | 1 | 2019 | 136 | 0.140 |
Why?
| | Male | 11 | 2025 | 67361 | 0.140 |
Why?
| | Liver Transplantation | 1 | 2025 | 871 | 0.140 |
Why?
| | Spontaneous Perforation | 1 | 2016 | 2 | 0.130 |
Why?
| | Treatment Outcome | 3 | 2024 | 10764 | 0.130 |
Why?
| | Prognosis | 3 | 2025 | 4018 | 0.130 |
Why?
| | United States | 8 | 2025 | 14660 | 0.130 |
Why?
| | Aortography | 1 | 2016 | 52 | 0.120 |
Why?
| | Registries | 4 | 2025 | 2015 | 0.120 |
Why?
| | Vena Cava Filters | 1 | 2016 | 61 | 0.120 |
Why?
| | Female | 10 | 2025 | 72840 | 0.120 |
Why?
| | Liver Neoplasms | 1 | 2022 | 784 | 0.120 |
Why?
| | Kidney Transplantation | 1 | 2022 | 700 | 0.120 |
Why?
| | Promoter Regions, Genetic | 1 | 2019 | 1250 | 0.110 |
Why?
| | Heart | 3 | 2023 | 656 | 0.110 |
Why?
| | Time Factors | 2 | 2023 | 6792 | 0.110 |
Why?
| | DNA Methylation | 1 | 2019 | 644 | 0.110 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2016 | 202 | 0.100 |
Why?
| | Adolescent | 2 | 2023 | 21463 | 0.100 |
Why?
| | Trauma Centers | 1 | 2016 | 422 | 0.100 |
Why?
| | Acute Coronary Syndrome | 1 | 2016 | 275 | 0.100 |
Why?
| | Insulin | 1 | 2023 | 2399 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2677 | 0.100 |
Why?
| | Hemostatic Techniques | 1 | 2012 | 47 | 0.090 |
Why?
| | Blood Loss, Surgical | 1 | 2012 | 100 | 0.090 |
Why?
| | Endovascular Procedures | 1 | 2016 | 315 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3566 | 0.090 |
Why?
| | Risk Assessment | 2 | 2023 | 3429 | 0.090 |
Why?
| | Hospital Mortality | 1 | 2016 | 900 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2108 | 0.090 |
Why?
| | Resuscitation | 1 | 2012 | 250 | 0.080 |
Why?
| | Survival Rate | 2 | 2025 | 1969 | 0.080 |
Why?
| | Pelvic Exenteration | 1 | 2009 | 11 | 0.080 |
Why?
| | Exercise | 1 | 2020 | 2038 | 0.080 |
Why?
| | Hemorrhage | 1 | 2012 | 723 | 0.070 |
Why?
| | Aged | 2 | 2024 | 23729 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 507 | 0.070 |
Why?
| | Stroke Volume | 2 | 2020 | 619 | 0.070 |
Why?
| | Colonoscopy | 1 | 2009 | 247 | 0.060 |
Why?
| | Biopsy | 1 | 2009 | 1126 | 0.060 |
Why?
| | Cohort Studies | 1 | 2016 | 5718 | 0.060 |
Why?
| | Young Adult | 1 | 2021 | 13126 | 0.060 |
Why?
| | Thoracic Surgical Procedures | 1 | 2024 | 73 | 0.050 |
Why?
| | Polyketide Synthases | 1 | 2022 | 5 | 0.050 |
Why?
| | Travel | 1 | 2023 | 129 | 0.050 |
Why?
| | Shock, Cardiogenic | 1 | 2022 | 63 | 0.050 |
Why?
| | Multigene Family | 1 | 2022 | 199 | 0.050 |
Why?
| | Hepacivirus | 1 | 2023 | 258 | 0.050 |
Why?
| | Coronary Angiography | 1 | 2023 | 312 | 0.050 |
Why?
| | Child | 1 | 2021 | 21968 | 0.040 |
Why?
| | Drainage | 1 | 2022 | 168 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2022 | 432 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 430 | 0.040 |
Why?
| | Risk Factors | 2 | 2025 | 10331 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 231 | 0.040 |
Why?
| | Critical Care | 1 | 2024 | 583 | 0.040 |
Why?
| | Echocardiography, Transesophageal | 1 | 2019 | 101 | 0.040 |
Why?
| | Quality of Health Care | 1 | 2023 | 627 | 0.040 |
Why?
| | Constriction, Pathologic | 1 | 2019 | 241 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1455 | 0.040 |
Why?
| | Exercise Test | 1 | 2020 | 625 | 0.030 |
Why?
| | Electrocardiography | 1 | 2020 | 628 | 0.030 |
Why?
| | Coronary Artery Disease | 1 | 2023 | 702 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 293 | 0.030 |
Why?
| | Cardiopulmonary Bypass | 1 | 2019 | 209 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2020 | 412 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 939 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2180 | 0.030 |
Why?
| | Blood Pressure | 1 | 2022 | 1772 | 0.030 |
Why?
| | Histones | 1 | 2019 | 635 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2836 | 0.030 |
Why?
| | Liver | 1 | 2022 | 1938 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 2223 | 0.030 |
Why?
| | Plasma Substitutes | 1 | 2012 | 3 | 0.030 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2012 | 9 | 0.020 |
Why?
| | Isotonic Solutions | 1 | 2012 | 38 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1619 | 0.020 |
Why?
| | Saline Solution, Hypertonic | 1 | 2012 | 41 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 5749 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2023 | 2624 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 1980 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2012 | 147 | 0.020 |
Why?
| | Plasma | 1 | 2012 | 213 | 0.020 |
Why?
| | Erythrocyte Transfusion | 1 | 2012 | 193 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 845 | 0.020 |
Why?
| | Mutation | 1 | 2019 | 3953 | 0.020 |
Why?
| | Hemodynamics | 1 | 2012 | 1110 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2012 | 802 | 0.020 |
Why?
| | Length of Stay | 1 | 2012 | 1208 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2012 | 3537 | 0.010 |
Why?
|
|
Hoffman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|